Medy-Tox Balance Sheet Health
Financial Health criteria checks 5/6
Medy-Tox has a total shareholder equity of ₩474.5B and total debt of ₩81.1B, which brings its debt-to-equity ratio to 17.1%. Its total assets and total liabilities are ₩611.6B and ₩137.1B respectively. Medy-Tox's EBIT is ₩17.3B making its interest coverage ratio 12.1. It has cash and short-term investments of ₩33.3B.
Key information
17.1%
Debt to equity ratio
₩81.08b
Debt
| Interest coverage ratio | 12.1x |
| Cash | ₩33.35b |
| Equity | ₩474.48b |
| Total liabilities | ₩137.14b |
| Total assets | ₩611.62b |
Recent financial health updates
No updates
Recent updates
Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think
Mar 31
Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares
Feb 27Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield
Apr 02A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns
Feb 09
Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend
Dec 18Financial Position Analysis
Short Term Liabilities: A086900's short term assets (₩166.2B) exceed its short term liabilities (₩126.6B).
Long Term Liabilities: A086900's short term assets (₩166.2B) exceed its long term liabilities (₩10.6B).
Debt to Equity History and Analysis
Debt Level: A086900's net debt to equity ratio (10.1%) is considered satisfactory.
Reducing Debt: A086900's debt to equity ratio has reduced from 32.6% to 17.1% over the past 5 years.
Debt Coverage: A086900's debt is not well covered by operating cash flow (16.7%).
Interest Coverage: A086900's interest payments on its debt are well covered by EBIT (12.1x coverage).